A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal Immunization
Trial details
- Registry ID
- NCT02624947
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Determine the Safety and Efficacy of the RSV F Vaccine to Protect Infants Via Maternal ImmunizationNCT02624947 | Novavax | Phase 3 | Completed | 2018-12-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |